PNC Financial Services Group Inc. Buys 6,347 Shares of Haleon PLC Sponsored ADR $HLN

PNC Financial Services Group Inc. grew its holdings in Haleon PLC Sponsored ADR (NYSE:HLN) by 2.7% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 238,188 shares of the company’s stock after purchasing an additional 6,347 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Haleon were worth $2,470,000 as of its most recent filing with the SEC.

Other institutional investors have also recently bought and sold shares of the company. Wellington Management Group LLP boosted its stake in Haleon by 22.0% during the 1st quarter. Wellington Management Group LLP now owns 18,700,480 shares of the company’s stock worth $192,428,000 after acquiring an additional 3,372,155 shares during the last quarter. Sculptor Capital LP grew its stake in shares of Haleon by 22.1% in the first quarter. Sculptor Capital LP now owns 10,849,868 shares of the company’s stock valued at $111,645,000 after buying an additional 1,962,770 shares in the last quarter. Envestnet Asset Management Inc. raised its holdings in shares of Haleon by 6.5% in the 2nd quarter. Envestnet Asset Management Inc. now owns 7,857,196 shares of the company’s stock valued at $81,479,000 after purchasing an additional 476,823 shares during the period. Nuveen LLC acquired a new position in shares of Haleon during the 1st quarter worth approximately $58,870,000. Finally, Acadian Asset Management LLC boosted its holdings in shares of Haleon by 3,031.5% during the 2nd quarter. Acadian Asset Management LLC now owns 5,384,661 shares of the company’s stock worth $55,813,000 after buying an additional 5,212,711 shares during the period. Institutional investors own 6.67% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have commented on HLN shares. The Goldman Sachs Group upgraded Haleon from a “neutral” rating to a “buy” rating in a research note on Wednesday, September 10th. Barclays lowered shares of Haleon from an “overweight” rating to an “equal weight” rating in a report on Tuesday, September 16th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Haleon in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $12.33.

Haleon Trading Down 0.8%

NYSE:HLN opened at $9.61 on Wednesday. The company has a market cap of $42.77 billion, a P/E ratio of 24.63, a P/E/G ratio of 2.92 and a beta of 0.20. Haleon PLC Sponsored ADR has a 1 year low of $8.71 and a 1 year high of $11.42. The stock’s fifty day moving average price is $9.27 and its two-hundred day moving average price is $9.90. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.87 and a quick ratio of 0.63.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.